Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Posted on by

The Lancet
Feb 12, 2022 Volume 399 Number 10325 p605-694
https://www.thelancet.com/journals/lancet/issue/current

 

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group
Open Access